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policy and questions whether it is an area in which 
any significant developments in terms of policy 
harmonisation have been made.
Background to integration of 
European drug policy 
At a relatively early stage in the development 
of European integration, the illicit drug problem 
was investigated as an area for potential closer 
co-operation between national governments. 
European commissions launched into drug 
problems in the 1980s and early 1990s failed to 
achieve any consensus on the best approach to 
combating the problem, being divided on whether 
a Dutch style of tolerance or a more traditional 
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in a policy that is stricter than that operated in 
many other European countries. Policies disallow 
the consumption of drugs (as compared to many 
European countries that only criminalise their 
possession), recognise no difference between soft 
and hard drugs, ensure that users are targeted 
with as much vigour as dealers and primarily 
invest in abstention-based or coercive treatment 
programmes. Tham (1995) describes the Swedish 
drug problem as having become entwined with 
national identity, with the life of the drug abuser 
being held up as the antithesis of the life of a good 
citizen. Drugs are seen as a problem that has come 
from outside Sweden and, as such, constitute a 
threat to the Swedish lifestyle (Gould, 1994); it is 
therefore an issue that supercedes party political 
interest and that requires the participation of all if 
it is to be overcome.
In the Netherlands, meanwhile, drug policy 
has been based on the principle of normalising 
the drug problem as far as possible (van Vliet, 
1990). Rather than seeking to stigmatise and 
marginalise drug users, pushing them to the 
outskirts of society, policy seeks to normalise their 
experience and include them within society as far 
as possible. Where they are treated as ‘different’, 
it is as patients in need of cure rather than as 
criminals in need of punishment. Pragmatic policy 
initiatives such as the ‘separation of the markets’ 
have been implemented whereby, in an effort to 
keep cannabis users away from potentially more 
damaging drugs, semi-legal environments (coffee 
shops) have been established where cannabis 
can be bought and consumed under some form of 
regulation. The overall aim, which has become 
as important a part of national identity to the 
Dutch as the pursuit of a drug-free society is to the 
Swedes, is to minimise the harm done to society 
by the use of drugs and, therefore, the principle 
of harm reduction has gained much ground here.
Recent developments in Swedish 
and Dutch drug policy
Sweden and the Netherlands have been often-
invoked examples of the different paradigms of 
drug policy in operation in Europe and it might 
therefore be expected that if European policy 
on this issue is to converge, some signs of that 
convergence would be observed within the recent 
policy developments of these two countries. Indeed, 
on a first perusal, evidence does suggest that some 
changes are being made to the policies of each 
country that indicate a dilution of their national 
positions on the drug policy issue. In Sweden, for 
control-oriented policy was the right direction for 
Europe as a whole (Blom & van Mastrigt, 1994). 
The European Union (EU) itself retired from 
attempts to judge the desirability of one method of 
drug control over another and, instead, drug policy 
has been defined as an area of subsidiarity, ie. one 
more suited to national control. Nevertheless, 
evidence exists to support the idea that the EU 
continues to prioritise illicit drug policy. Extensive 
numbers of working bodies and groups have been 
created to monitor the problem and the European 
Parliament, the Commission and the Council of 
Europe have all become involved with the issue. 
The abundance of activity within the EU in this 
area is indicative of the fact that the underlying aim 
is far from having been abandoned (Boekhout van 
Solinge, 2002). What, then, have been the effects 
of all this prioritising and activity; are we seeing any 
real convergence in European drug policy?
Before answering this question, it is important 
to establish the existence of two different 
paradigms of drug policy that exist at the 
European level (Chatwin, 2003; 2007). Each EU 
member state has developed a highly nationalised 
response to the illicit drug problem, sometimes 
involving fundamentally different basic principles 
that are in almost direct opposition to each 
other in terms of finding and implementing 
different solutions, which has, of course, made 
attempts at harmonisation difficult. In the areas 
of drug dealing and drug trafficking, European 
consensus has been less difficult to achieve, 
with all member states avowedly against both 
behaviours. Considerable headway, in terms of 
harmonisation, has already been made in this 
area, as evidenced by the implementation of 
agreed minimum penalties across Europe for these 
offences, although agreement on the actual terms 
of these penalties was not straightforward. It is in 
the areas of drug use and drug users, however, that 
accord has generally been much more difficult 
to reach. The drug policies of the Netherlands 
and Sweden offer good examples of the two 
different extremes of drug policy operating within 
Europe and thus deserve a brief exploration here. 
Other European member states differ along the 
continuum between them. 
In Sweden, drug policy is strictly control-
oriented and moralistic, operating as a cross-
political party issue where policy is endorsed 
by wider society in its entirety (Boekhout van 
Solinge, 1997; Goldberg, 2004; Lenke & Olsson, 
2002). The ultimate aim, realistic or not, is to 
achieve a drug-free society, which has resulted 
Have recent evolutions in European governance brought harmonisation of illicit drugs closer?
28   Drugs and Alcohol Today  •  Volume 10 Issue 4  •  December 2010 © Pier Professional
So, at face value, if Swedish drug policy is 
becoming more liberal and Dutch drug policy is 
becoming more repressive, then there are some 
signs of convergence of drug policy ideals at a 
European level. However, while the changes 
described above are certainly noteworthy, there is 
plenty of evidence to suggest that, despite them, 
national drug policy in both Sweden and the 
Netherlands is mainly one of continuation of past 
policy goals. While public perception of the drug 
problem and the centre right government of the 
Netherlands have certainly had some impact on 
policy implementations, many liberal elements of 
Dutch drug policy remain, suggesting it still has a 
place at the forefront of European harm reduction 
and tolerant drug policy practice. The heroin 
trials that began in 1998 were extended in 2001 
after an overwhelmingly positive evaluation (van 
Kolfschooten, 2002). Additionally, the last decade 
has seen the Dutch become increasingly involved 
in promoting the potential use of cannabis as a 
medicine in its own right, particularly in treating 
multiple sclerosis (Sheldon, 2002). At the end 
of 2007, despite relatively disappointing take-up 
of this treatment option, the Minister of Health, 
Welfare and Sport announced that development of 
the medicinal use of cannabis would be extended 
for a further five years (de Jong, 2009).
In Sweden, while the new policy instructions 
regarding needle exchange programmes and 
substitution treatment do promise a new 
attitude towards harm reduction measures, the 
overwhelming message of drug policy remains 
strictly control oriented. The report of the drug 
commission appointed in 1998 to examine the 
drug problem in light of rising levels of drug use, 
demands stronger leadership in drug policy and 
a more active role from the government in a new 
offensive against the drug problem. The strict 
policy of control with regard to drugs is reiterated 
and enforced: ‘In its choice of direction, the Drugs 
Commission has found that Sweden’s restrictive 
policy on drugs must be sustained and reinforced’ 
(Swedish Commission on Narcotic Drugs, 2000, 
p2). Furthermore, since the implementation 
of this report via national action plans in 
2002 and 2006, Sweden has seen a decrease in 
levels of drug use since the highs of the 1990s 
(CAN – Council for Information on Alcohol 
and Other Drugs, 2009). The United Nations 
Office for Drug Control has seized on this, while 
ignoring Sweden’s high proportion of heavy 
drug users and drug-related deaths (Cohen, 
2006; Ramstedt, 2006), and published a report 
example, academics have noted two recent policy 
initiatives that suggest the Swedish government 
may be loosening its grip on illicit drug control 
policy (Goldberg, 2005; Johnson, 2006). Firstly, 
the Drugs Commissioner has recommended that 
the needle exchange programmes in southern 
Sweden, which have only ever been tolerated on a 
temporary basis, albeit an ongoing one, should be 
made permanent. Secondly, he has recommended 
that a greater number and a greater variety 
of substitution treatment programmes should be 
made available to problem drug users. Taken 
together, Goldberg (2005) and Johnson (2006), 
among others, have reflected that these aims 
may represent a shift towards the acceptance of 
the principles of harm reduction not previously 
seen in Sweden, as harm reduction does not sit 
well within the framework of a drug-free society. 
This new consideration for improving the lives 
of drug users may indicate a fundamental shift in 
the ‘foundations on which the strategy of the drug free 
society is built’ (Hallam, 2010, p9).
Similarly, in the Netherlands, academics have 
begun to notice a shift in drug policy, this time 
towards repression (Uitermark, 2004; Lemmens, 
2003). Since 2003, a centre-right cabinet has been 
in power within the Netherlands, resulting in an 
increasing tendency for politicians to appear tough 
on drugs. This has combined with a decreasing 
willingness from the general public to tolerate drug-
related public nuisance (Garretsen, 2003), resulting 
in a number of policy changes. Since 1995, local 
authorities in Holland have been granted the power 
to ban coffee shops completely from their confines 
or to close them where regulations are clearly being 
contravened (Boekhaut van Solinge, 1999) and 
current figures (Intraval, 2007) show that there has 
been a recent decrease in both the overall number 
of coffee shops and the number of towns/cities with 
any coffee shops at all. This example illustrates 
how external pressure to normalise cannabis policy 
has coincided with internal pressure to reduce 
drug-related public nuisance to effect concrete 
policy changes, which, interestingly, have been 
implemented here at the local rather than national 
level. There is also evidence of an increasingly law-
enforcement-based policy towards ecstasy use and 
users, probably as a result of the rising role of the 
Netherlands as a producer of this drug (Uitermark 
& Cohen, 2005). Finally, the alarming rise in 
prison numbers for drug-related crimes (Goldberg, 
2005, p53) is an indication that ‘power in the drug 
field is moving from the Ministry of Health to the 
Ministry of Justice’.
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in the case of small amounts for personal use 
of any drug; and Spain, the Czech Republic 
and Latvia have gone one step further, making 
administrative sanctions the norm for possession 
of small amounts of illegal drugs for personal use. 
Furthermore, in France – a traditional supporter 
of a control-oriented, Swedish style of drug policy 
– a reduction in both the number and length of 
sentences for drug use has been observed since 
1998 (Bergeron & Kopp, 2002). Perhaps the most 
convincing example of this alternative trend 
towards liberalisation of drug policy, however, 
is provided by recent efforts to decriminalise all 
drugs in Portugal in 2001. The latest evaluations of 
this policy initiative have declared it a ‘resounding 
success’ (Greenwald, 2009, p1), resulting in a 
reduction in drug trafficking, drug-related deaths 
and heroin use while maintaining a relatively 
low lifetime usage rate for cannabis (Economist, 
2009). Furthermore, Hedrich and colleagues 
(2008, p512) have noted a ‘clear trend across 
Europe towards recognition of harm reduction as an 
important component of mainstream public health and 
social policies towards problem drug use’. MacGregor 
& Whiting (2010) have noted that this is a trend 
that has permeated the powerhouses of the EU 
itself, as evidenced by the latest EU Drugs Action 
Plan 2009–2012 (European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA), 2008), 
which refers explicitly to harm reduction as a 
guiding principle in reducing drug-related death 
and disease. Even here, however, policy consensus 
is not absolute, as a lack of appropriate funding 
has made it difficult for the further expansion of 
harm reduction in central and eastern European 
countries (World Health Organization Department 
of Mental Health and Substance Abuse, 2004).
Conclusion
Based on the evidence presented above, it is 
very difficult to argue that any real signs of 
convergence can yet be seen in European drug 
policy. Despite cosmetic changes, neither Sweden 
nor the Netherlands have committed to any 
change in their respective underlying principles 
of drug control. Change in other countries cannot 
be said to show any convincing direction or 
cohesion, either. This is a somewhat surprising 
turn of events, particularly if we consider what has 
happened in similar policy areas at the European 
level. For example, in the area of alcohol policy, 
convergence can clearly be seen. Prior to entrance 
to the EU, Nordic countries had uniquely control-
orientated alcohol policies in comparison with 
entitled Sweden’s Successful Drug Policy (United 
Nations Office on Drugs and Crime, 2007). This 
endorsement of Sweden’s drug policy is further 
likely to ensure that no significant changes in 
terms of operating a less restrictive policy are to 
be expected.
Seeds of change in European 
drug policy?
It can thus be observed that, while both Sweden 
and the Netherlands have made minor concessions 
in their national drug policies, possibly as a nod to 
differing styles of drug policy operating in Europe, 
in the main they have remained unchanged, 
despite a focus on harmonisation in this area. If we 
now turn to look at drug policy in a greater variety 
of European member states, we can further observe 
no overall coherent direction for the recent 
changes that have been made. With Sweden 
overwhelmingly in favour of a continuation of its 
strict drug policy, and the impact of a centre right 
government and a decrease in public tolerance 
of drug related nuisance in the Netherlands, 
evidence so far suggests a trend towards repression 
in European drug policy. Such a trend can be 
further evidenced by the legitimacy of increasingly 
severe penalties towards drug traffickers seen 
in Europe, which is ‘deepening the culture of 
prohibition … [and ensures] the dichotomy at the 
heart of European drug policy remains as strong as 
ever: harmonisation and toughening of enforcement 
measures’ (Elvins, 2003, p182). Cohen (2000, p4) 
suggests that drug policy is still operating as an 
‘arena’ for politicians across Europe, who are more 
interested in vote-winning rhetoric focused on 
control measures than implementing real changes. 
To further emphasise this point, if we consider a 
country such as Denmark, which has long been 
accepted as operating a policy that is caught 
between a desire to be liberal and a reality of being 
heavily influenced by other repressive Nordic 
policies, Laursen and Jepsen (2002, p22) observe 
that the recent closure of the free cannabis market 
in Christiania and the general toughening of 
measures against cannabis users means ‘the battle 
between repression and welfare seems likely to give 
priority to repression in actual practice’. 
Taking the rest of Europe, however, this trend 
towards repression is not upheld. For example, 
Belgium and Luxembourg have recently effectively 
removed criminal sanctions for the possession of 
cannabis for personal use. Germany, Estonia and 
Lithuania, meanwhile, have written into their 
penal codes the possibility of waiving prosecution 
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2003; Small et al, 2005). Klein (2008) cautions 
against further harmonisation: ‘Global recipes of 
failure…have only served to spread drug related 
problems across ever wider parts of the globe’. Dorn 
(1996a), however, postulates that if drug policy 
remains ultimately in the hands of individual 
countries, it will converge more because decisions 
will continue to be made by those in power for 
each country. Both he and Klein (2008, p3) call 
instead for a policy that is based on decision-
making at the local rather than the national level. 
Dorn (1996b) further links the development of 
a local-level response to the drug problem to a 
system of sharing incidences of best practice in 
similar areas at the European level. As there exists 
no policy that could so far be called successful 
in eradicating the drug problem, it therefore 
makes sense for as many different policy options 
to be in operation as possible and for these to be 
implemented at the local level, independent of 
national policy. The real issue here is whether 
individual countries have become so locked into 
their own paradigms that they are unable to learn 
from other countries or from identifiable policies 
of best practice, for example for urban areas. 
While, ultimately, it does not matter whether or 
not Europe achieves unity of policy style in this 
area, it does make sense to work together on the 
issue and for individual nation states to be able 
to pick and choose from a variety of drug policy 
implementations developed at the local level to 
best suit their own drug problem.
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